Back to search

Article

Adjudicating mild cognitive impairment due to Alzheimer’s disease as a novel endpoint event in the TOMMORROW prevention clinical trial

2021-08-19

Abstract excerpt

<title>Abstract</title> <p>Background The onset of mild cognitive impairment (MCI) is an essential outcome in Alzheimer’s disease (AD) prevention trials and a compelling milestone for clinically meaningful change. Determining MCI, however, may be variable and subject to disagreement. Adjudication procedures may improve the reliability of these determinations. We report the performance of an adjudication committe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98e206fc-e225-5019-b791-e8eadc70ca81
DOI
10.21203/rs.3.rs-806031/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adjudicating mild cognitive impairment due to Alzheimer’s disease as a novel endpoint event in the TOMMORROW prevention clinical trialDOI 10.21203/rs.3.rs-806031/v1
Select a neighboring publication to make it the new centre.